ERAZABAN
As listed in the register: ERAZABAN 100 mg/g, crème
100 mg · crème
- Prescription status not stated
- Active substance
- Docosanol
- Made by
- PHOENIX HEALTHCARE (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States49 matching products
- Docosanol 100 mg/g · CreamWithout prescription26 makers
- Cold Sore Fever Blister Treatment 100 mg/g · CreamWithout prescription14 makers
- Cold Sore Treatment 100 mg/g · CreamWithout prescription3 makers
- Cold Sore Fever Blister 100 mg/g · CreamWithout prescription2 makers
- Abreva 100 mg/g · CreamWithout prescription
- Amazon Basics Docosanol 100 mg/g · CreamWithout prescription
- Cold Sore Treatment Docosanol 100 mg/g · CreamWithout prescription
- Julie Cold Sore Treatment 100 mg/g · CreamWithout prescription
Details
| Made by | PHOENIX HEALTHCARE (IRLANDE) |
|---|---|
| Active substance | Docosanol |
| Strength | 100 mg |
| Form | crème |
| Route | cutanée |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure de reconnaissance mutuelle |
| Name in the register | ERAZABAN 100 mg/g, crème |
| Packs | 1 tube(s) aluminium verni de 2 g |
| CIS | 66326694 |
| CIP13 | 3400938041538 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).